Clinical trial / 2009
Beta-glycan supplementation elevated interleukin-10 but did not modify insulin sensitivity in overweight adults.
In a crossover study, 12 overweight or obese participants took 1.5 grams daily of purified (1,3)(1,6)-beta-D-glycan or waxy maize placebo for 4 weeks each. Beta-glycan intake significantly raised circulating concentrations and adipose mRNA expression of anti-inflammatory interleukin-10. Nevertheless, peripheral insulin sensitivity and levels of pro-inflammatory cytokines remained unchanged by the fiber treatment.
- Study type
- Randomized crossover trial
- Who was studied
- 12 overweight or obese adults with elevated C-reactive protein
- What was measured
- Circulating cytokines, adipose tissue gene expression, and insulin sensitivity
THE PAPER
Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-beta-glycan consumption in overweight humans.
Kohl A, Gögebakan O, Möhlig M, Osterhoff M, Isken F, Pfeiffer AF, Weickert MO. Nutr Res, 2009.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.